Effect of human seminal plasma on tumour-associated immunity in prostatic cancer. A preliminary report

R. J. Ablin, R. A. Bhatti, P. D. Guinan, I. M. Bush

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Evidence of significant suppression of tumour-associated immunity in patients with prostatic cancer by human seminal plasma (HuSP1) has been observed. Collation of the immunosuppressive property of HuSP1 in this and previous studies, together with recent studies demonstrating experimental induction of prostatic cancer by spermatozoa and the relationship of prostatic cancer to sexual activity are suggestive of an etiologic role for SP1 in prostatic cancer.

Original languageEnglish (US)
Pages (from-to)1510-1511
Number of pages2
JournalExperientia
Volume35
Issue number11
DOIs
StatePublished - Nov 1979
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint

Dive into the research topics of 'Effect of human seminal plasma on tumour-associated immunity in prostatic cancer. A preliminary report'. Together they form a unique fingerprint.

Cite this